GENTAUR Belgium BVBA BE0473327336 Voortstraat 49, 1910 Kampenhout BELGIUM Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc,Logistics 547 Yurok Circle, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, [email protected]

Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, Gentaur another in time delivery

Cyclin-D1-binding protein 1 (Grap2 and cyclin-D-interacting protein) (Human homolog of Maid)

 CCDB1_HUMAN             Reviewed;         360 AA.
O95273; A8K3Q0; A8K3U2; Q6ZQN9; Q7Z519; Q8NBS7; Q8NBY2; Q9NS19; Q9NYH3;
Q9UHX9;
18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
18-MAR-2008, sequence version 2.
11-DEC-2019, entry version 132.
RecName: Full=Cyclin-D1-binding protein 1;
AltName: Full=Grap2 and cyclin-D-interacting protein;
AltName: Full=Human homolog of Maid;
Name=CCNDBP1; Synonyms=DIP1, GCIP, HHM;
Homo sapiens (Human).
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
Homo.
NCBI_TaxID=9606;
[1]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH CCND1, SUBCELLULAR
LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND PHOSPHORYLATION.
PubMed=10854051; DOI=10.1006/excr.2000.4884;
Yao Y., Doki Y., Jiang W., Imoto M., Venkatraj V.S., Warburton D.,
Santella R.M., Lu B., Yan L., Sun X.-H., Su T., Luo J., Weinstein I.B.;
"Cloning and characterization of DIP1, a novel protein that is related to
the Id family of proteins.";
Exp. Cell Res. 257:22-32(2000).
[2]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH TCF3, AND TISSUE
SPECIFICITY.
TISSUE=Liver;
PubMed=10915743; DOI=10.1053/jhep.2000.9092;
Terai S., Aoki H., Thorgeirsson S.S.;
"Human homologue of maid: a dominant inhibitory helix-loop-helix protein
associated with liver-specific gene expression.";
Hepatology 32:357-366(2000).
[3]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH CCND1
AND GRAP2, AND TISSUE SPECIFICITY.
TISSUE=Liver;
PubMed=10801854; DOI=10.1074/jbc.m002598200;
Xia C., Bao Z., Tabassam F., Ma W., Qiu M., Hua S., Liu M.;
"GCIP, a novel human grap2 and cyclin D interacting protein, regulates E2F-
mediated transcriptional activity.";
J. Biol. Chem. 275:20942-20948(2000).
[4]
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
Gao J., Yu L., Mao N.H., Wan Y.Z., Yang Y.M., Zhao S.Y.;
"Cloning and characterization of a novel human cDNA homologous to murine
Maid mRNA.";
Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
TISSUE=Hypothalamus;
PubMed=10931946; DOI=10.1073/pnas.160270997;
Hu R.-M., Han Z.-G., Song H.-D., Peng Y.-D., Huang Q.-H., Ren S.-X.,
Gu Y.-J., Huang C.-H., Li Y.-B., Jiang C.-L., Fu G., Zhang Q.-H., Gu B.-W.,
Dai M., Mao Y.-F., Gao G.-F., Rong R., Ye M., Zhou J., Xu S.-H., Gu J.,
Shi J.-X., Jin W.-R., Zhang C.-K., Wu T.-M., Huang G.-Y., Chen Z.,
Chen M.-D., Chen J.-L.;
"Gene expression profiling in the human hypothalamus-pituitary-adrenal axis
and full-length cDNA cloning.";
Proc. Natl. Acad. Sci. U.S.A. 97:9543-9548(2000).
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
"Cloning of human full open reading frames in Gateway(TM) system entry
vector (pDONR201).";
Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
[7]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
TISSUE=Hair follicle dermal papilla, Lung, Retinoblastoma, and Trachea;
PubMed=14702039; DOI=10.1038/ng1285;
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
Isogai T., Sugano S.;
"Complete sequencing and characterization of 21,243 full-length human
cDNAs.";
Nat. Genet. 36:40-45(2004).
[8]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
TISSUE=Placenta;
PubMed=16303743; DOI=10.1093/dnares/12.2.117;
Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
Isogai T.;
"Signal sequence and keyword trap in silico for selection of full-length
human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
libraries.";
DNA Res. 12:117-126(2005).
[9]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
Hunkapiller M.W., Myers E.W., Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[10]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
TISSUE=Pancreas;
PubMed=15489334; DOI=10.1101/gr.2596504;
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project:
the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[11]
INTERACTION WITH SYF2.
PubMed=11118353; DOI=10.1006/bbrc.2000.3992;
Chang M.-S., Chang C.-L., Huang C.-J., Yang Y.-C.;
"p29, a novel GCIP-interacting protein, localizes in the nucleus.";
Biochem. Biophys. Res. Commun. 279:732-737(2000).
[12]
TISSUE SPECIFICITY, AND INTERACTION WITH COPS5.
PubMed=15887118; DOI=10.1053/j.gastro.2005.03.014;
Takami T., Terai S., Yokoyama Y., Tanimoto H., Tajima K., Uchida K.,
Yamasaki T., Sakaida I., Nishina H., Thorgeirsson S.S., Okita K.;
"Human homologue of maid is a useful marker protein in
hepatocarcinogenesis.";
Gastroenterology 128:1369-1380(2005).
[13]
INTERACTION WITH SIRT6, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND
INDUCTION.
PubMed=17131381; DOI=10.1002/jcb.21140;
Ma W., Stafford L.J., Li D., Luo J., Li X., Ning G., Liu M.;
"GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis.";
J. Cell. Biochem. 100:1376-1386(2007).
[14]
INTERACTION WITH RPLP0, AND SUBCELLULAR LOCATION.
PubMed=17621266; DOI=10.1038/sj.onc.1210651;
Chang T.-W., Chen C.-C., Chen K.-Y., Su J.-H., Chang J.-H., Chang M.-C.;
"Ribosomal phosphoprotein P0 interacts with GCIP and overexpression of P0
is associated with cellular proliferation in breast and liver carcinoma
cells.";
Oncogene 27:332-338(2008).
[15]
ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
[LARGE SCALE ANALYSIS].
PubMed=22814378; DOI=10.1073/pnas.1210303109;
Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
"N-terminal acetylome analyses and functional insights of the N-terminal
acetyltransferase NatB.";
Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
-!- FUNCTION: May negatively regulate cell cycle progression. May act at
least in part via inhibition of the cyclin-D1/CDK4 complex, thereby
preventing phosphorylation of RB1 and blocking E2F-dependent
transcription. {ECO:0000269|PubMed:10801854}.
-!- SUBUNIT: Interacts with CCND1 and GRAP2. May also interact with COPS5,
RPLP0, SIRT6, SYF2 and TCF3. {ECO:0000269|PubMed:10801854,
ECO:0000269|PubMed:10854051, ECO:0000269|PubMed:10915743,
ECO:0000269|PubMed:11118353, ECO:0000269|PubMed:15887118,
ECO:0000269|PubMed:17131381, ECO:0000269|PubMed:17621266}.
-!- INTERACTION:
B0FTY2:-; NbExp=3; IntAct=EBI-748961, EBI-10175366;
B2R4U6:-; NbExp=3; IntAct=EBI-748961, EBI-10175477;
F4ZW62:-; NbExp=3; IntAct=EBI-748961, EBI-10177680;
Q5XG85:-; NbExp=3; IntAct=EBI-748961, EBI-10248413;
Q8N9J2:-; NbExp=3; IntAct=EBI-748961, EBI-10268244;
Q96BA2:-; NbExp=3; IntAct=EBI-748961, EBI-10282278;
Q01433:AMPD2; NbExp=3; IntAct=EBI-748961, EBI-8796759;
Q7Z5H3:ARHGAP22; NbExp=3; IntAct=EBI-748961, EBI-3866859;
P51164:ATP4B; NbExp=3; IntAct=EBI-748961, EBI-3904463;
Q9BZE7:C22orf23; NbExp=3; IntAct=EBI-748961, EBI-10303102;
Q5I0X4:C6orf226; NbExp=3; IntAct=EBI-748961, EBI-10244057;
Q8IYE0-2:CCDC146; NbExp=3; IntAct=EBI-748961, EBI-10247802;
Q07002:CDK18; NbExp=3; IntAct=EBI-748961, EBI-746238;
Q6ZU64-3:CFAP65; NbExp=3; IntAct=EBI-748961, EBI-10255250;
Q8NE01:CNNM3; NbExp=3; IntAct=EBI-748961, EBI-741032;
Q92905:COPS5; NbExp=5; IntAct=EBI-748961, EBI-594661;
Q93034:CUL5; NbExp=3; IntAct=EBI-748961, EBI-1057139;
Q9NQL9:DMRT3; NbExp=3; IntAct=EBI-748961, EBI-9679045;
Q92608:DOCK2; NbExp=3; IntAct=EBI-748961, EBI-448771;
Q92731-3:ESR2; NbExp=3; IntAct=EBI-748961, EBI-12259414;
Q9BQ89:FAM110A; NbExp=3; IntAct=EBI-748961, EBI-1752811;
A0A0S2Z6M9:FAM126A; NbExp=3; IntAct=EBI-748961, EBI-16428876;
Q9BYI3:FAM126A; NbExp=3; IntAct=EBI-748961, EBI-11065686;
Q3B820:FAM161A; NbExp=4; IntAct=EBI-748961, EBI-719941;
Q5TZK3:FAM74A6; NbExp=5; IntAct=EBI-748961, EBI-10247271;
A0A0S2Z408:FH; NbExp=3; IntAct=EBI-748961, EBI-16428900;
Q9Y2Q3:GSTK1; NbExp=3; IntAct=EBI-748961, EBI-1053767;
Q02363:ID2; NbExp=4; IntAct=EBI-748961, EBI-713450;
Q9NV31:IMP3; NbExp=5; IntAct=EBI-748961, EBI-747481;
P36507:MAP2K2; NbExp=3; IntAct=EBI-748961, EBI-1056930;
P00540:MOS; NbExp=3; IntAct=EBI-748961, EBI-1757866;
Q9P015:MRPL15; NbExp=6; IntAct=EBI-748961, EBI-2371967;
Q69YI7:NAIF1; NbExp=3; IntAct=EBI-748961, EBI-10249231;
P60321:NANOS2; NbExp=3; IntAct=EBI-748961, EBI-10216569;
Q60867:Neurod1 (xeno); NbExp=4; IntAct=EBI-748961, EBI-309315;
O75928:PIAS2; NbExp=4; IntAct=EBI-748961, EBI-348555;
Q9BSJ6:PIMREG; NbExp=6; IntAct=EBI-748961, EBI-2568609;
P02689:PMP2; NbExp=3; IntAct=EBI-748961, EBI-10193858;
Q8WWY3:PRPF31; NbExp=4; IntAct=EBI-748961, EBI-1567797;
P40306:PSMB10; NbExp=4; IntAct=EBI-748961, EBI-603329;
P82980:RBP5; NbExp=3; IntAct=EBI-748961, EBI-3941274;
P46779:RPL28; NbExp=6; IntAct=EBI-748961, EBI-366357;
Q96EH5:RPL39L; NbExp=3; IntAct=EBI-748961, EBI-6658607;
P05388:RPLP0; NbExp=4; IntAct=EBI-748961, EBI-354101;
P62857:RPS28; NbExp=3; IntAct=EBI-748961, EBI-353027;
P55042:RRAD; NbExp=5; IntAct=EBI-748961, EBI-3911502;
Q9UQ90:SPG7; NbExp=3; IntAct=EBI-748961, EBI-717201;
O95926:SYF2; NbExp=3; IntAct=EBI-748961, EBI-2557644;
P15923-1:TCF3; NbExp=3; IntAct=EBI-748961, EBI-769645;
D3DUQ6:TEAD4; NbExp=3; IntAct=EBI-748961, EBI-10176734;
A0A024R4Q5:TFPT; NbExp=3; IntAct=EBI-748961, EBI-11527449;
Q9P2Z0:THAP10; NbExp=4; IntAct=EBI-748961, EBI-745404;
Q9BT49:THAP7; NbExp=3; IntAct=EBI-748961, EBI-741350;
A0PK00:TMEM120B; NbExp=3; IntAct=EBI-748961, EBI-10171534;
Q8IUR0:TRAPPC5; NbExp=5; IntAct=EBI-748961, EBI-3246160;
Q5W5X9:TTC23; NbExp=3; IntAct=EBI-748961, EBI-6447954;
Q8TAI1:TYMSOS; NbExp=3; IntAct=EBI-748961, EBI-742060;
O43167:ZBTB24; NbExp=3; IntAct=EBI-748961, EBI-744471;
Q8N5A5:ZGPAT; NbExp=4; IntAct=EBI-748961, EBI-3439227;
Q15973:ZNF124; NbExp=3; IntAct=EBI-748961, EBI-2555767;
P52737:ZNF136; NbExp=4; IntAct=EBI-748961, EBI-749129;
Q14929:ZNF169; NbExp=3; IntAct=EBI-748961, EBI-10234472;
P17024:ZNF20; NbExp=5; IntAct=EBI-748961, EBI-717634;
Q9UIE0:ZNF230; NbExp=3; IntAct=EBI-748961, EBI-1105361;
Q9HCZ1:ZNF334; NbExp=3; IntAct=EBI-748961, EBI-748965;
Q53GI3:ZNF394; NbExp=3; IntAct=EBI-748961, EBI-10211248;
Q8TAU3:ZNF417; NbExp=3; IntAct=EBI-748961, EBI-740727;
Q8NDP4:ZNF439; NbExp=3; IntAct=EBI-748961, EBI-747580;
Q9ULM2:ZNF490; NbExp=3; IntAct=EBI-748961, EBI-1105370;
Q8NEP9:ZNF555; NbExp=3; IntAct=EBI-748961, EBI-10270752;
Q8TBZ8:ZNF564; NbExp=3; IntAct=EBI-748961, EBI-10273713;
Q9P0T4:ZNF581; NbExp=3; IntAct=EBI-748961, EBI-745520;
Q7L945:ZNF627; NbExp=4; IntAct=EBI-748961, EBI-2797561;
Q9BS34:ZNF670; NbExp=5; IntAct=EBI-748961, EBI-745276;
Q8N508:ZNF697; NbExp=3; IntAct=EBI-748961, EBI-10265733;
Q96C28:ZNF707; NbExp=5; IntAct=EBI-748961, EBI-748111;
Q16670:ZSCAN26; NbExp=3; IntAct=EBI-748961, EBI-3920053;
-!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus.
-!- ALTERNATIVE PRODUCTS:
Event=Alternative splicing; Named isoforms=4;
Name=1;
IsoId=O95273-1; Sequence=Displayed;
Name=2;
IsoId=O95273-2; Sequence=VSP_032014, VSP_032015;
Name=3;
IsoId=O95273-3; Sequence=VSP_032012;
Name=4;
IsoId=O95273-4; Sequence=VSP_032012, VSP_032013, VSP_032016;
-!- TISSUE SPECIFICITY: Ubiquitously expressed. Expression is down-
regulated in a variety of tumor types including breast, colon, prostate
and rectal tumors, and is up-regulated in certain hepatic carcinomas.
{ECO:0000269|PubMed:10801854, ECO:0000269|PubMed:10854051,
ECO:0000269|PubMed:10915743, ECO:0000269|PubMed:15887118,
ECO:0000269|PubMed:17131381}.
-!- DEVELOPMENTAL STAGE: Expression may increase during differentiation.
{ECO:0000269|PubMed:10854051}.
-!- INDUCTION: Expression is induced by sodium butyrate, an inhibitor of
colon cancer cell proliferation. {ECO:0000269|PubMed:17131381}.
-!- PTM: Phosphorylated. {ECO:0000269|PubMed:10854051}.
-!- SIMILARITY: Belongs to the CCNDBP1 family. {ECO:0000305}.
-!- SEQUENCE CAUTION:
Sequence=AAD11777.1; Type=Frameshift; Evidence={ECO:0000305};
Sequence=AAP97163.1; Type=Frameshift; Evidence={ECO:0000305};
---------------------------------------------------------------------------
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
---------------------------------------------------------------------------
EMBL; AF082569; AAD11777.1; ALT_FRAME; mRNA.
EMBL; AF132034; AAF77613.1; -; mRNA.
EMBL; AF246144; AAF67182.1; -; mRNA.
EMBL; AF087852; AAP97163.1; ALT_FRAME; mRNA.
EMBL; AF113535; AAF14872.1; -; mRNA.
EMBL; CR450331; CAG29327.1; -; mRNA.
EMBL; AK075296; BAC11530.1; -; mRNA.
EMBL; AK128849; BAC87645.1; -; mRNA.
EMBL; AK290665; BAF83354.1; -; mRNA.
EMBL; AK290707; BAF83396.1; -; mRNA.
EMBL; AK075146; BAC11433.1; -; mRNA.
EMBL; CH471125; EAW92588.1; -; Genomic_DNA.
EMBL; CH471125; EAW92590.1; -; Genomic_DNA.
EMBL; BC009689; AAH09689.1; -; mRNA.
CCDS; CCDS10092.1; -. [O95273-1]
RefSeq; NP_036274.3; NM_012142.4. [O95273-1]
PDB; 3AY5; X-ray; 2.50 A; A=1-360.
PDBsum; 3AY5; -.
SMR; O95273; -.
BioGrid; 117117; 106.
IntAct; O95273; 136.
MINT; O95273; -.
STRING; 9606.ENSP00000300213; -.
iPTMnet; O95273; -.
PhosphoSitePlus; O95273; -.
BioMuta; CCNDBP1; -.
EPD; O95273; -.
jPOST; O95273; -.
MassIVE; O95273; -.
MaxQB; O95273; -.
PaxDb; O95273; -.
PeptideAtlas; O95273; -.
PRIDE; O95273; -.
ProteomicsDB; 50774; -. [O95273-1]
ProteomicsDB; 50775; -. [O95273-2]
ProteomicsDB; 50776; -. [O95273-3]
ProteomicsDB; 50777; -. [O95273-4]
DNASU; 23582; -.
Ensembl; ENST00000300213; ENSP00000300213; ENSG00000166946. [O95273-1]
Ensembl; ENST00000565296; ENSP00000455419; ENSG00000166946. [O95273-2]
Ensembl; ENST00000566515; ENSP00000456797; ENSG00000166946. [O95273-2]
GeneID; 23582; -.
KEGG; hsa:23582; -.
UCSC; uc001zqv.4; human. [O95273-1]
CTD; 23582; -.
DisGeNET; 23582; -.
EuPathDB; HostDB:ENSG00000166946.13; -.
GeneCards; CCNDBP1; -.
HGNC; HGNC:1587; CCNDBP1.
HPA; CAB020664; -.
HPA; HPA041065; -.
MIM; 607089; gene.
neXtProt; NX_O95273; -.
OpenTargets; ENSG00000166946; -.
PharmGKB; PA26154; -.
eggNOG; ENOG410II9T; Eukaryota.
eggNOG; ENOG410ZPHZ; LUCA.
GeneTree; ENSGT00390000018016; -.
InParanoid; O95273; -.
KO; K21626; -.
OMA; YYWLPKS; -.
OrthoDB; 1249310at2759; -.
PhylomeDB; O95273; -.
TreeFam; TF336444; -.
ChiTaRS; CCNDBP1; human.
GeneWiki; CCNDBP1; -.
GenomeRNAi; 23582; -.
Pharos; O95273; Tbio.
PRO; PR:O95273; -.
Proteomes; UP000005640; Chromosome 15.
RNAct; O95273; protein.
Bgee; ENSG00000166946; Expressed in 200 organ(s), highest expression level in bone marrow.
ExpressionAtlas; O95273; baseline and differential.
Genevisible; O95273; HS.
GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
GO; GO:0016604; C:nuclear body; IDA:HPA.
GO; GO:0005654; C:nucleoplasm; IDA:HPA.
GO; GO:0005634; C:nucleus; IDA:MGI.
GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
GO; GO:0051726; P:regulation of cell cycle; IEA:InterPro.
InterPro; IPR026907; CCNDBP1.
PANTHER; PTHR15492; PTHR15492; 1.
1: Evidence at protein level;
3D-structure; Acetylation; Alternative splicing; Cell cycle; Cytoplasm;
Nucleus; Phosphoprotein; Reference proteome.
INIT_MET 1
/note="Removed"
/evidence="ECO:0000244|PubMed:22814378"
CHAIN 2..360
/note="Cyclin-D1-binding protein 1"
/id="PRO_0000323372"
REGION 2..208
/note="Required for interaction with CCND1"
REGION 2..190
/note="Interaction with RPLP0"
/evidence="ECO:0000269|PubMed:17621266"
REGION 2..184
/note="Interaction with TCF3"
/evidence="ECO:0000269|PubMed:10915743"
REGION 150..360
/note="Interaction with TCF3"
/evidence="ECO:0000269|PubMed:10915743"
REGION 240..360
/note="Interaction with RPLP0"
/evidence="ECO:0000269|PubMed:17621266"
MOD_RES 2
/note="N-acetylalanine"
/evidence="ECO:0000244|PubMed:22814378"
VAR_SEQ 1..128
/note="Missing (in isoform 3 and isoform 4)"
/evidence="ECO:0000303|PubMed:10931946,
ECO:0000303|PubMed:14702039"
/id="VSP_032012"
VAR_SEQ 308..333
/note="SAKLVSVLKKALEITKASHVTPQPED -> VSTGFEGIATEQMGRISLITSI
SCK (in isoform 4)"
/evidence="ECO:0000303|PubMed:14702039"
/id="VSP_032013"
VAR_SEQ 308..309
/note="SA -> EP (in isoform 2)"
/evidence="ECO:0000303|PubMed:16303743"
/id="VSP_032014"
VAR_SEQ 310..360
/note="Missing (in isoform 2)"
/evidence="ECO:0000303|PubMed:16303743"
/id="VSP_032015"
VAR_SEQ 334..360
/note="Missing (in isoform 4)"
/evidence="ECO:0000303|PubMed:14702039"
/id="VSP_032016"
CONFLICT 40
/note="A -> D (in Ref. 1; AAD11777)"
/evidence="ECO:0000305"
CONFLICT 41
/note="Q -> R (in Ref. 4; AAP97163)"
/evidence="ECO:0000305"
CONFLICT 74
/note="F -> S (in Ref. 8; BAC11433)"
/evidence="ECO:0000305"
CONFLICT 211
/note="N -> S (in Ref. 8; BAC11433)"
/evidence="ECO:0000305"
CONFLICT 235
/note="E -> G (in Ref. 7; BAF83396)"
/evidence="ECO:0000305"
CONFLICT 267
/note="K -> R (in Ref. 7; BAC87645)"
/evidence="ECO:0000305"
CONFLICT 274
/note="L -> M (in Ref. 1; AAD11777 and 3; AAF67182)"
/evidence="ECO:0000305"
CONFLICT 310
/note="K -> R (in Ref. 7; BAC11530)"
/evidence="ECO:0000305"
CONFLICT 334
/note="S -> I (in Ref. 7; BAF83354)"
/evidence="ECO:0000305"
HELIX 17..29
/evidence="ECO:0000244|PDB:3AY5"
HELIX 31..36
/evidence="ECO:0000244|PDB:3AY5"
HELIX 49..73
/evidence="ECO:0000244|PDB:3AY5"
STRAND 76..78
/evidence="ECO:0000244|PDB:3AY5"
HELIX 82..103
/evidence="ECO:0000244|PDB:3AY5"
HELIX 108..110
/evidence="ECO:0000244|PDB:3AY5"
HELIX 112..137
/evidence="ECO:0000244|PDB:3AY5"
HELIX 154..160
/evidence="ECO:0000244|PDB:3AY5"
TURN 161..164
/evidence="ECO:0000244|PDB:3AY5"
HELIX 169..197
/evidence="ECO:0000244|PDB:3AY5"
HELIX 235..265
/evidence="ECO:0000244|PDB:3AY5"
HELIX 271..295
/evidence="ECO:0000244|PDB:3AY5"
STRAND 296..298
/evidence="ECO:0000244|PDB:3AY5"
HELIX 301..324
/evidence="ECO:0000244|PDB:3AY5"
HELIX 335..352
/evidence="ECO:0000244|PDB:3AY5"
HELIX 353..358
/evidence="ECO:0000244|PDB:3AY5"
SEQUENCE 360 AA; 40262 MW; 40C7C3686632F6A7 CRC64;
MASATAPAAA VPTLASPLEQ LRHLAEELRL LLPRVRVGEA QETTEEFNRE MFWRRLNEAA
VTVSREATTL TIVFSQLPLP SPQETQKFCE QVHAAIKAFI AVYYLLPKDQ GITLRKLVRG
ATLDIVDGMA QLMEVLSVTP TQSPENNDLI SYNSVWVACQ QMPQIPRDNK AAALLMLTKN
VDFVKDAHEE MEQAVEECDP YSGLLNDTEE NNSDNHNHED DVLGFPSNQD LYWSEDDQEL
IIPCLALVRA SKACLKKIRM LVAENGKKDQ VAQLDDIVDI SDEISPSVDD LALSIYPPMC
HLTVRINSAK LVSVLKKALE ITKASHVTPQ PEDSWIPLLI NAIDHCMNRI KELTQSELEL


Related products :

Catalog number Product name Quantity
EIAAB06056 CCNDBP1,Cyclin-D1-binding protein 1,DIP1,GCIP,Grap2 and cyclin-D-interacting protein,HHM,Homo sapiens,Human,Human homolog of Maid
EIAAB06053 Ccndbp1,Cyclin-D1-binding protein 1,Dip1,Gcip,Grap2 and cyclin-D-interacting protein,Maid,Maternal Id-like protein,Mouse,Mus musculus,SSEC-8,Stage specific embryonic cDNA-8 protein
EIAAB11493 Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1,DMP1,DMTF1,hDMP1,hDMTF1,Homo sapiens,Human
EIAAB11494 Cyclin-D-binding Myb-like transcription factor 1,Cyclin-D-interacting Myb-like protein 1,Dmp1,Dmtf1,mDmp1,Mouse,Mus musculus
EIAAB06187 C10orf9,CBCP1,CCNY,CFP1,Cyclin box protein 1,Cyclin fold protein 1,cyclin-X,Cyclin-Y,Cyc-Y,Homo sapiens,Human
orb80776 Human cyclin-C protein Cyclin Recombinant is expressed in E.coli as 35kDa tagged fusion protein corresponding to amino acids 120-303 of Cyclin of human origin. Cyclin is purified from bacterial lysate 2
EIAAB06559 CDI1,CDK2-associated dual-specificity phosphatase,CDKN3,CIP2,Cyclin-dependent kinase inhibitor 3,Cyclin-dependent kinase interactor 1,Cyclin-dependent kinase-interacting protein 2,Homo sapiens,Human,K
EIAAB07414 CDK2-interacting protein,CINP,Cyclin-dependent kinase 2-interacting protein,Homo sapiens,Human
EIAAB39347 Mouse,Mus musculus,Spata24,Spermatogenesis-associated protein 24,TATA-binding protein-like factor-interacting protein,Testis protein T6441 homolog,Tipt,Tipt2,TLF-interacting protein,TRF2-interacting p
EIAAB41849 Dopamine receptor-interacting protein 5,DRIP5,Homo sapiens,hRap1,Human,PP8000,RAP1,RAP1 homolog,Repressor_activator protein 1 homolog,Telomeric repeat-binding factor 2-interacting protein 1,TERF2-inte
EIAAB41848 Bos taurus,Bovine,RAP1,RAP1 homolog,Repressor_activator protein 1 homolog,Telomeric repeat-binding factor 2-interacting protein 1,TERF2-interacting telomeric protein 1,TERF2IP,TRF2-interacting telomer
EIAAB41846 Rap1,RAP1 homolog,Rat,Rattus norvegicus,Repressor_activator protein 1 homolog,Telomeric repeat-binding factor 2-interacting protein 1,TERF2-interacting telomeric protein 1,Terf2ip,TRF2-interacting tel
EIAAB29754 Homo sapiens,HSPC218,Human,PABP-interacting protein 2,PAIP2,PAIP-2,PAIP2A,Poly(A)-binding protein-interacting protein 2,Polyadenylate-binding protein-interacting protein 2
EIAAB29748 Homo sapiens,Human,KIAA1155,PABP-interacting protein 2B,PAIP2B,PAIP-2B,Poly(A)-binding protein-interacting protein 2B,Polyadenylate-binding protein-interacting protein 2B
pka-269 Recombinant Human Cyclin-Dependent Kinase 2 Interacting Protein PROTEIN KINASES 1mg
pka-269 Recombinant Human Cyclin-Dependent Kinase 2 Interacting Protein PROTEIN KINASES 20
pka-269 Recombinant Human Cyclin-Dependent Kinase 2 Interacting Protein PROTEIN KINASES 5
EIAAB37520 Homo sapiens,Human,KIAA1454,MSTP063,S phase cyclin A-associated protein in the endoplasmic reticulum,S phase cyclin A-associated protein in the ER,SCAPER,Zinc finger protein 291,ZNF291
EIAAB29749 Homo sapiens,Human,PABP-interacting protein 1,PAIP1,PAIP-1,Poly(A)-binding protein-interacting protein 1,Polyadenylate-binding protein-interacting protein 1
E14061h Human Cyclin B1 Interacting Protein 1 ELISA Kit 96T
E7501h Human Protein Interacting With Cyclin A1 ELISA Kit 96T
pka-269 Recombinant Human Cyclin-Dependent Kinase 2 Interacting Protein 1mg
pka-269 Recombinant Human Cyclin-Dependent Kinase 2 Interacting Protein 5
RPK-269 Recombinant Human Cyclin-Dependent Kinase 2 Interacting Protein 5
pka-269 Recombinant Human Cyclin-Dependent Kinase 2 Interacting Protein 20
Pathways :
WP2292: Chemokine signaling pathway
WP1531: Vitamin D synthesis
WP731: Sterol regulatory element binding protein related
WP1616: ABC transporters
WP1693: Purine metabolism
WP35: G Protein Signaling Pathways
WP1650: Fluorobenzoate degradation
WP211: BMP signaling pathway
WP2203: TSLP Signaling Pathway
WP1165: G Protein Signaling Pathways
WP1713: Two-component system
WP525: Mitochondrial Unfolded-Protein Response
WP1659: Glycine, serine and threonine metabolism
WP655: p53 pathway
WP1665: Limonene and pinene degradation
WP1438: Influenza A virus infection
WP1892: Protein folding
WP1675: Nitrogen metabolism
WP1685: Peptidoglycan biosynthesis
WP2361: Gastric cancer network 1
WP1939: Unfolded Protein Response
WP1644: DNA replication
WP1692: Protein export
WP346: Protein Modifications
WP1700: Selenoamino acid metabolism

Related Genes :
[CCNDBP1 DIP1 GCIP HHM] Cyclin-D1-binding protein 1 (Grap2 and cyclin-D-interacting protein) (Human homolog of Maid)
[CCND1 BCL1 PRAD1] G1/S-specific cyclin-D1 (B-cell lymphoma 1 protein) (BCL-1) (BCL-1 oncogene) (PRAD1 oncogene)
[MAGED1 NRAGE PP2250 PRO2292] Melanoma-associated antigen D1 (MAGE tumor antigen CCF) (MAGE-D1 antigen) (Neurotrophin receptor-interacting MAGE homolog)
[CDKD-1 R2 Os05g0392300 LOC_Os05g32600 OJ1764_D01.12] Cyclin-dependent kinase D-1 (CDKD;1) (EC 2.7.11.22) (EC 2.7.11.23) (CDC2+/CDC28-related protein kinase R2) (CDK-activating kinase R2) (CAK-R2)
[CCNB1IP1 C14orf18 HEI10] E3 ubiquitin-protein ligase CCNB1IP1 (EC 2.3.2.27) (Cyclin-B1-interacting protein 1) (Human enhancer of invasion 10) (RING-type E3 ubiquitin transferase CCNB1IP1)
[CDK1 CDC2 CDC28A CDKN1 P34CDC2] Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)
[CDKN3 CDI1 CIP2 KAP] Cyclin-dependent kinase inhibitor 3 (EC 3.1.3.16) (EC 3.1.3.48) (CDK2-associated dual-specificity phosphatase) (Cyclin-dependent kinase interactor 1) (Cyclin-dependent kinase-interacting protein 2) (Kinase-associated phosphatase)
[DNAJB11 EDJ ERJ3 HDJ9 PSEC0121 UNQ537/PRO1080] DnaJ homolog subfamily B member 11 (APOBEC1-binding protein 2) (ABBP-2) (DnaJ protein homolog 9) (ER-associated DNAJ) (ER-associated Hsp40 co-chaperone) (Endoplasmic reticulum DNA J domain-containing protein 3) (ER-resident protein ERdj3) (ERdj3) (ERj3p) (HEDJ) (Human DnaJ protein 9) (hDj-9) (PWP1-interacting protein 4)
[Ccnd1 Cyl-1] G1/S-specific cyclin-D1
[Ccnd1] G1/S-specific cyclin-D1
[Dmtf1 Dmp1] Cyclin-D-binding Myb-like transcription factor 1 (Cyclin-D-interacting Myb-like protein 1) (mDmp1)
[CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1] Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein 6) (MDA-6) (p21)
[CDKN2A CDKN2 MTS1] Cyclin-dependent kinase inhibitor 2A (Cyclin-dependent kinase 4 inhibitor A) (CDK4I) (Multiple tumor suppressor 1) (MTS-1) (p16-INK4a) (p16-INK4) (p16INK4A)
[Cdk1 Cdc2 Cdc2a Cdkn1] Cyclin-dependent kinase 1 (CDK1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog) (Cell division protein kinase 1) (p34 protein kinase)
[CDK7 CAK CAK1 CDKN7 MO15 STK1] Cyclin-dependent kinase 7 (EC 2.7.11.22) (EC 2.7.11.23) (39 kDa protein kinase) (p39 Mo15) (CDK-activating kinase 1) (Cell division protein kinase 7) (Serine/threonine-protein kinase 1) (TFIIH basal transcription factor complex kinase subunit)
[PCL2 CLN4 YDL127W D2223] PHO85 cyclin-2 (Cyclin HCS26 homolog) (G1/S-specific cyclin PCL2)
[PRMT5 HRMT1L5 IBP72 JBP1 SKB1] Protein arginine N-methyltransferase 5 (PRMT5) (EC 2.1.1.320) (72 kDa ICln-binding protein) (Histone-arginine N-methyltransferase PRMT5) (Jak-binding protein 1) (Shk1 kinase-binding protein 1 homolog) (SKB1 homolog) (SKB1Hs) [Cleaved into: Protein arginine N-methyltransferase 5, N-terminally processed]
[tat] Protein Tat (Transactivating regulatory protein)
[CDK2 CDKN2] Cyclin-dependent kinase 2 (EC 2.7.11.22) (Cell division protein kinase 2) (p33 protein kinase)
[MEPCE BCDIN3] 7SK snRNA methylphosphate capping enzyme (MePCE) (EC 2.1.1.-) (Bicoid-interacting protein 3 homolog) (Bin3 homolog)
[CDKA-1 CDC2 CDC2A At3g48750 T21J18.20] Cyclin-dependent kinase A-1 (CDKA;1) (EC 2.7.11.22) (EC 2.7.11.23) (Cell division control protein 2 homolog A) (CDC2aAt)
[tat] Protein Tat (Transactivating regulatory protein)
[Maged1 Nrage] Melanoma-associated antigen D1 (MAGE-D1 antigen) (Neurotrophin receptor-interacting MAGE homolog) (Sertoli cell necdin-related gene protein 1) (SNERG-1)
[TSC22D1 KIAA1994 TGFB1I4 TSC22 hucep-2] TSC22 domain family protein 1 (Cerebral protein 2) (Regulatory protein TSC-22) (TGFB-stimulated clone 22 homolog) (Transforming growth factor beta-1-induced transcript 4 protein)
[CDK4] Cyclin-dependent kinase 4 (EC 2.7.11.22) (Cell division protein kinase 4) (PSK-J3)
[EGFR ERBB ERBB1 HER1] Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1)
[tat] Protein Tat (Transactivating regulatory protein)
[CCND3] G1/S-specific cyclin-D3
[CCND2] G1/S-specific cyclin-D2
[CCNA2 CCN1 CCNA] Cyclin-A2 (Cyclin-A) (Cyclin A)

Bibliography :
No related Items